These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17644174)

  • 1. Competitive-protein adsorption in contact activation of blood factor XII.
    Zhuo R; Siedlecki CA; Vogler EA
    Biomaterials; 2007 Oct; 28(30):4355-69. PubMed ID: 17644174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoactivation of blood factor XII at hydrophilic and hydrophobic surfaces.
    Zhuo R; Siedlecki CA; Vogler EA
    Biomaterials; 2006 Aug; 27(24):4325-32. PubMed ID: 16644008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group.
    Golas A; Pitakjakpipop H; Rahn MS; Siedlecki CA; Vogler EA
    Biomaterials; 2015 Jan; 37():1-12. PubMed ID: 25443791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderation of prekallkrein-factor XII interactions in surface activation of coagulation by protein-adsorption competition.
    Chatterjee K; Thornton JL; Bauer JW; Vogler EA; Siedlecki CA
    Biomaterials; 2009 Oct; 30(28):4915-20. PubMed ID: 19552950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact activation of blood plasma and factor XII by ion-exchange resins.
    Josh Yeh CH; Dimachkie ZO; Golas A; Cheng A; Parhi P; Vogler EA
    Biomaterials; 2012 Jan; 33(1):9-19. PubMed ID: 21982294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contact activation of blood-plasma coagulation.
    Vogler EA; Siedlecki CA
    Biomaterials; 2009 Apr; 30(10):1857-69. PubMed ID: 19168215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of blood factor XII autoactivation in buffer, protein cocktail, serum, and plasma solutions.
    Golas A; Yeh CH; Pitakjakpipop H; Siedlecki CA; Vogler EA
    Biomaterials; 2013 Jan; 34(3):607-20. PubMed ID: 23117212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of contact activation pathways of coagulation factor XII in plasma.
    Chatterjee K; Guo Z; Vogler EA; Siedlecki CA
    J Biomed Mater Res A; 2009 Jul; 90(1):27-34. PubMed ID: 18481791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FXII contact activation products have an inhibitory effect on αFXIIa.
    Xu LC; Siedlecki CA
    J Biomed Mater Res A; 2024 Aug; 112(8):1213-1223. PubMed ID: 37737653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface dependent contact activation of factor XII and blood plasma coagulation induced by mixed thiol surfaces.
    Bauer JW; Xu LC; Vogler EA; Siedlecki CA
    Biointerphases; 2017 May; 12(2):02D410. PubMed ID: 28514863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procoagulant activity of surface-immobilized Hageman factor.
    Chatterjee K; Vogler EA; Siedlecki CA
    Biomaterials; 2006 Nov; 27(33):5643-50. PubMed ID: 16905185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amidolytic, procoagulant, and activation-suppressing proteins produced by contact activation of blood factor XII in buffer solution.
    Golas A; Yeh CH; Siedlecki CA; Vogler EA
    Biomaterials; 2011 Dec; 32(36):9747-57. PubMed ID: 21955686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical application of a chromogenic FXIIa assay.
    Zhuo R; Vogler EA
    Biomaterials; 2006 Oct; 27(28):4840-5. PubMed ID: 16765435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical modeling of material-induced blood plasma coagulation.
    Guo Z; Bussard KM; Chatterjee K; Miller R; Vogler EA; Siedlecki CA
    Biomaterials; 2006 Feb; 27(5):796-806. PubMed ID: 16099033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.
    Mutch NJ; Waters EK; Morrissey JH
    J Thromb Haemost; 2012 Oct; 10(10):2108-15. PubMed ID: 22905925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XII truncation accelerates activation in solution.
    de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
    J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factor XII (FXII): its relevance as a useful parameter for the in vitro assessment of haemodialysis membranes.
    Matata BM; Courtney JM; Sundaram S; Wark S; Bowry SK; Vienken J; Lowe GD
    J Biomed Mater Res; 1996 May; 31(1):63-70. PubMed ID: 8731150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XII in coagulation, inflammation and beyond.
    Didiasova M; Wujak L; Schaefer L; Wygrecka M
    Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet surface-associated activation and secretion-mediated inhibition of coagulation factor XII.
    Zakharova NV; Artemenko EO; Podoplelova NA; Sveshnikova AN; Demina IA; Ataullakhanov FI; Panteleev MA
    PLoS One; 2015; 10(2):e0116665. PubMed ID: 25688860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.